🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effective Therapy Targeting Cytochrome bc 1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00662-21Source: DataRank Database

Effective Therapy Targeting Cytochrome bc 1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection is a research paper published in Antimicrobial Agents and Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)OA: greenTopics (23)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Isaline Renard ORCID,Anasuya Pal ORCID,Pallavi Singh ORCID,Pratap Vydyam ORCID,Jose Thekkiniath ORCID

Live enrichment

PubMed:34152821 PMC:PMC8370247

HHS | National Institutes of Health

Grant: R01AI123321

HHS | National Institutes of Health

Grant: R01AI138139

HHS | National Institutes of Health

Grant: R01AI152220

HHS | National Institutes of Health

Grant: R01AI136118

HHS | National Institutes of Health

Grant: R01AI100569

HHS | National Institutes of Health

Grant: R01AI141412

Steven and Alexandra Cohen Foundation

Grant: Lyme 62 2020

U.S. Department of Defense

Grant: Log # PR181134

U.S. Department of Veterans Affairs

Grant: 1I01BX003312

NCATS NIH HHS

Grant: UL1 TR001863

NIAID NIH HHS

Grant: R01 AI153100

NIAID NIH HHS

Grant: R44 AI136118

BLRD VA

Grant: I01 BX004522

BLRD VA

Grant: I01 BX003312

NIAID NIH HHS

Grant: R43 AI136118

National Institutes of Health

Grant: 5R44AI136118-03

An antigen-detection assay to diagnose Babesia microti infection

National Institutes of Health

Grant: 1R01AI141412-01A1

Development of a Sustained Release Injectable Formulation for Long-Term Delivery of ELQs

National Institutes of Health

Grant: 5R01AI123321-02

Development of endochin-like quinolones for babesiosis therapy

National Institutes of Health

Grant: 1R01AI138139-01A1

Hit-to-Lead Development of the Kalihinol Scaffold for Malaria Treatment

National Institutes of Health

Grant: 5R01AI100569-12

Novel Therapeutics to Target Parasite Cytochrome bc1

National Institutes of Health

Grant: 5R01AI152220-02

Antigen Discovery and Vaccine Development for Human Babesia Parasites

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8370247

publisherhttps://journals.asm.org/doi/pdf/10.1128/AAC.00662-21

https://doi.org/10.1128/aac.00662-21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370247

https://pubmed.ncbi.nlm.nih.gov/34152821

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsMiceBabesiaParasitemiaBabesiosisCytochromesAtovaquone

Keywords

Red blood cellsTherapyParasitologyBabesiosisBabesia MicrotiApicomplexan ParasitesBabesia DuncaniEndochin-like QuinoloneMiceAnimalsBabesiaCytochromesParasitemiaAtovaquone

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (9)

Human babesiosis

International Journal for Parasitology(2019)

OpenAlex related

10.1016/j.ijpara.2018.11.007

Chemotherapy against babesiosis

Veterinary Parasitology(2006)

OpenAlex related

10.1016/j.vetpar.2006.01.048

Antiprotozoal treatment of canine babesiosis

Veterinary Parasitology(2018)

OpenAlex related

10.1016/j.vetpar.2018.03.001

Synthesis and in vitro activities of ferrocenic aminohydroxynaphthoquinones against Toxoplasma gondii and Plasmodium falciparum

Bioorganic & Medicinal Chemistry(2005)

OpenAlex related

10.1016/j.bmc.2005.09.054

Treatment of Human Babesiosis: Then and Now

Pathogens(2021)

OpenAlex related

10.3390/pathogens10091120

Human Babesiosis

Infectious Disease Clinics of North America(2022)

OpenAlex related

10.1016/j.idc.2022.02.009

Therapeutic Efficacy of Atovaquone against the Bovine Intraerythrocytic Parasite, Babesia divergens

Journal of Parasitology(1997)

OpenAlex related

10.2307/3284461

Recurrence of Human Babesiosis Caused by Reinfection

Emerging infectious diseases(2021)

OpenAlex related

10.3201/eid2710.211240

Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts

Frontiers in Cellular and Infection Microbiology(2022)

OpenAlex related

10.3389/fcimb.2022.1048962